Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Tagawa

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Cancer Science|July 5, 2007
Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer developmentHiroyuki Tagawa, Kennosuke Karube, Shinobu Tsuzuki, et al.
Blood Advances|February 16, 2018
Hypoxia-inducible KDM3A addiction in multiple myelomaSho Ikeda, Akihiro Kitadate, Fumito Abe, et al.
Cancer Medicine|February 13, 2023
Hypoxia-induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase-1 in multiple myelomaKo Abe, Sho Ikeda, Miho Nara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphomaYumiko Kasugai, Hiroyuki Tagawa, Yoshihiro Kameoka, et al.
Genes, Chromosomes & Cancer|April 30, 2002
Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell linesHiroyuki Tagawa, Ikuo Miura, Ritsuro Suzuki, et al.
Cancer Science|August 14, 2020
Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myelomaSho Ikeda, Fumito Abe, Yuka Matsuda, et al.
Blood|October 23, 2008
MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypesMika Inomata, Hiroyuki Tagawa, Yong-Mei Guo, et al.
Oncogene|December 24, 2003
MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8Hiroyuki Tagawa, Sivasundram Karnan, Yumiko Kasugai, et al.
Blood|July 18, 2009
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomasKeiichiro Honma, Shinobu Tsuzuki, Masao Nakagawa, et al.
Haematologica|October 14, 2017
Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomasAkihiro Kitadate, Sho Ikeda, Fumito Abe, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Cancer Science|July 5, 2007
Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer developmentHiroyuki Tagawa, Kennosuke Karube, Shinobu Tsuzuki, et al.
Blood Advances|February 16, 2018
Hypoxia-inducible KDM3A addiction in multiple myelomaSho Ikeda, Akihiro Kitadate, Fumito Abe, et al.
Cancer Medicine|February 13, 2023
Hypoxia-induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase-1 in multiple myelomaKo Abe, Sho Ikeda, Miho Nara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphomaYumiko Kasugai, Hiroyuki Tagawa, Yoshihiro Kameoka, et al.
Genes, Chromosomes & Cancer|April 30, 2002
Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell linesHiroyuki Tagawa, Ikuo Miura, Ritsuro Suzuki, et al.
Cancer Science|August 14, 2020
Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myelomaSho Ikeda, Fumito Abe, Yuka Matsuda, et al.
Blood|October 23, 2008
MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypesMika Inomata, Hiroyuki Tagawa, Yong-Mei Guo, et al.
Oncogene|December 24, 2003
MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8Hiroyuki Tagawa, Sivasundram Karnan, Yumiko Kasugai, et al.
Blood|July 18, 2009
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomasKeiichiro Honma, Shinobu Tsuzuki, Masao Nakagawa, et al.
Haematologica|October 14, 2017
Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomasAkihiro Kitadate, Sho Ikeda, Fumito Abe, et al.
Pageof 8